HireQuest, Heidrick & Struggles and Cross Country Healthcare have been highlighted in this Industry Outlook article.

Meta Platforms and NVIDIA have been highlighted in this Investment Ideas article.

You have $1,000 (or $200 or $50,000) burning a hole in your pocket and you're itching to invest in some stocks. Verizon Communications (NYSE: VZ) is another company that has seen its stock drop and its dividend rise; it was recently yielding a hefty 6.6%.

One of Wall Street's most-famous activist investors continues to pare back his fund's core position in Chipotle, while rapidly building up his stake in a beaten-down retailer.

As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the department store industry, including Dillard's (NYSE:DDS) and its peers.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Expeditors (NYSE:EXPD) and the rest of the air freight and logistics stocks fared in Q4.

Within 45 days of the end of each quarter, fund managers with over $100 million in assets under management must file a 13F with the Securities and Exchange Commission (SEC) disclosing what stocks they owned at the end of each quarter. Perhaps a nuisance for fund managers, these forms are closely monitored by retail investors who can't wait to see what the most experienced professional investors are buying and selling and get a glimpse into how some of the brightest investing minds in the world view the market. No 13F is more anticipated than the one from Warren Buffett's company, Berkshire Hathaway, which has a roughly $300 billion equities portfolio.

In the dark days of the coronavirus pandemic, Moderna (NASDAQ: MRNA) was a ray of light in more ways than one. The healthcare company's innovative Spikevax was one of the go-to vaccines that sped to market, not only protecting hundreds of millions of people from COVID-19, but also producing gobs of revenue and healthy profits. Wolfe Research's Alexandria Hammond now feels Moderna will be trading at around $25 per share a year from now, well down from her previous price target of $35.

Q4 2024 TrueCar Inc Earnings Call

Carvana Co (CVNA) reports a 50% increase in retail units sold and sets new financial records, while navigating operational and market challenges.